Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Lung Cancer (Amsterdam, Netherlands)|April 16, 2004
Fundamental principals of tumor necrosis factor-alpha gene therapy approach and implications for patients with lung carcinomaAhter D Sanlioglu, Cigdem Aydin, Hakan Bozcuk, et al.Methods in Molecular Biology (Clifton, N.J.)|July 15, 2018
High-Grade Purification of Third-Generation HIV-Based Lentiviral Vectors by Anion Exchange Chromatography for Experimental Gene and Stem Cell Therapy ApplicationsHazal Banu Olgun, Hale M Tasyurek, Ahter D Sanlioglu, et al.Expert Reviews in Molecular Medicine|March 31, 2025
Advancing CRISPR genome editing into gene therapy clinical trials: progress and future prospectsBusra Cetin, Fulya Erendor, Yunus Emre Eksi, et al.Journal of Cellular and Molecular Medicine|September 8, 2024
Gene and cell therapy of human genetic diseases: Recent advances and future directionsBusra Cetin, Fulya Erendor, Yunus E Eksi, et al.Urologic Oncology|March 4, 2008
Tumor necrosis factor-related apoptosis inducing ligand-R4 decoy receptor expression is correlated with high Gleason scores, prostate-specific antigen recurrence, and decreased survival in patients with prostate carcinomaIsmail T Koksal, Ahter D Sanlioglu, Bahri Karacay, et al.Journal of Molecular Endocrinology|September 20, 2012
Therapeutic potential of VIP vs PACAP in diabetesAhter D Sanlioglu, Bahri Karacay, Mustafa Kemal Balci, et al.World Journal of Stem Cells|July 12, 2021
Genome engineering and disease modeling via programmable nucleases for insulin gene therapy; promises of CRISPR/Cas9 technologyYunus E Eksi, Ahter D Sanlioglu, Bahar Akkaya, et al.BMC Cancer|May 27, 2005
Surface TRAIL decoy receptor-4 expression is correlated with TRAIL resistance in MCF7 breast cancer cellsAhter D Sanlioglu, Ercument Dirice, Cigdem Aydin, et al.Virus Research|June 5, 2004
Novel approaches to augment adeno-associated virus type-2 endocytosis and transductionAhter D Sanlioglu, Bahri Karacay, Peter K Benson, et al.Human Gene Therapy|April 16, 2021
Current Update on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development with a Special Emphasis on Gene Therapy Viral Vector Design and Construction for VaccinationAtil Bisgin, Ahter D Sanlioglu, Yunus Emre Eksi, et al.Pageof 2